These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11354277)

  • 41. The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
    Tsai MC; Chen CH; Lee CM; Chen YT; Chien YS; Hung CH; Wang JH; Lu SN; Yen YH; Changchien CS; Hu TH
    J Hepatol; 2009 Feb; 50(2):281-8. PubMed ID: 19070392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleic acid sequence analysis of basal core promoter/precore/core region of hepatitis B virus isolated from chronic carriers of the virus from Kolkata, eastern India: low frequency of mutation in the precore region.
    Banerjee A; Banerjee S; Chowdhury A; Santra A; Chowdhury S; Roychowdhury S; Panda CK; Bhattacharya SK; Chakravarty R
    Intervirology; 2005; 48(6):389-99. PubMed ID: 16024943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.
    Brunetto MR; Giarin M; Saracco G; Oliveri F; Calvo P; Capra G; Randone A; Abate ML; Manzini P; Capalbo M
    Gastroenterology; 1993 Sep; 105(3):845-50. PubMed ID: 7689519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers.
    Tsubota A; Kumada H; Takaki K; Chayama K; Kobayashi M; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Murashima N; Ikeda K
    J Med Virol; 1998 Dec; 56(4):287-93. PubMed ID: 9829631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
    Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
    Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
    Lee JH; Hong SP; Jang ES; Park SJ; Hwang SG; Kang SK; Jeong SH
    J Med Virol; 2015 Jun; 87(6):993-8. PubMed ID: 25712861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
    Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
    BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.
    Nagasaka A; Hige S; Marutani M; Tsunematsu I; Saito M; Yamamoto Y; Konishi S; Asaka M
    Dig Dis Sci; 1998 Nov; 43(11):2473-8. PubMed ID: 9824137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
    Cho SW; Hahm KB; Kim JH
    Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers.
    Jardi R; Rodriguez F; Buti M; Costa X; Valdes A; Allende H; Schaper M; Galimany R; Esteban R; Guardia J
    J Hepatol; 2004 Mar; 40(3):507-14. PubMed ID: 15123367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population.
    Biswas A; Banerjee A; Chandra PK; Datta S; Panigrahi R; Dutta D; De BK; Pal M; Guha SK; Chakrabarti S; Chakravarty R
    J Med Virol; 2011 Feb; 83(2):253-60. PubMed ID: 21181919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naturally occurring hepatitis B virus core gene mutations.
    Akarca US; Lok AS
    Hepatology; 1995 Jul; 22(1):50-60. PubMed ID: 7601433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B.
    Erhardt A; Reineke U; Blondin D; Gerlich WH; Adams O; Heintges T; Niederau C; Häussinger D
    Hepatology; 2000 Mar; 31(3):716-25. PubMed ID: 10706563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection.
    Marrone A; Zampino R; Luongo G; Utili R; Karayiannis P; Ruggiero G
    Intervirology; 2003; 46(4):222-6. PubMed ID: 12931030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.